Local role for tumor necrosis factor alpha in the pulmonary inflammatory response to Mycobacterium tuberculosis infection

被引:49
作者
Smith, S
Liggitt, D
Jeromsky, E
Tan, XX
Skerrett, SJ
Wilson, CB
机构
[1] Univ Washington, Dept Pediat, Seattle, WA 98195 USA
[2] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA
[3] Univ Washington, Dept Med, Seattle, WA 98195 USA
[4] Univ Washington, Dept Immunol, Seattle, WA 98195 USA
关键词
D O I
10.1128/IAI.70.4.2082-2089.2002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The local intrapulmonary role of tumor necrosis factor alpha (TNF-alpha) in a protective host response during acute and chronic infection with Mycobacterium tuberculosis is incompletely understood. To directly assess its role in the intrapulmonary immune response, we compared the responses of transgenic mice with a local pulmonary blockade of TNF-alpha (SPCTNFRIIFc mice) to mice with globally inhibited TNF-alpha (TNFRKO mice) and mice with normal immune systems (control mice). Consistent with previous reports, 100% of TNFRKO mice died by 28 days after aerosol infection, and these mice had markedly increased numbers of bacteria and widespread tissue necrosis in their lungs compared to controls. The median survival time of the SPCTNFRIIFc mice was 142 days, and 75% died by 180 days. Even though the numbers of bacteria in the lungs of the SPCTNFRIIFc mice were marginally increased compared to controls, these mice had a persistent neutrophilic inflammatory response and increased expression of proinflammatory cytokines (interleukin-1alpha/beta [IL-1alpha/beta], IL-18, gamma interferon, IL-6, and macrophage migration inhibitory factor) and chemokines (eotaxin, macrophage inflammatory protein 1alpha/beta, gamma interferon-inducible protein 10, macrophage chemotaxic protein 1, and TCA-3) in their lungs. These studies with the SPCTNFRIIFc mice provide direct evidence for the local importance of TNF-alpha in the proper regulation of host defense to M. tuberculosis. The studies also suggest that when the local actions of TNF-alpha are selectively impaired in the lungs, tissue destruction and death ensue, at least in part, due to persistent expression of proinflammatory mediators that would normally be downregulated.
引用
收藏
页码:2082 / 2089
页数:8
相关论文
共 31 条
[1]   EXACERBATION OF ACUTE AND CHRONIC MURINE TUBERCULOSIS BY ADMINISTRATION OF A TUMOR-NECROSIS-FACTOR RECEPTOR-EXPRESSING ADENOVIRUS [J].
ADAMS, LB ;
MASON, CM ;
KOLLS, JK ;
SCOLLARD, D ;
KRAHENBUHL, JL ;
NELSON, S .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (02) :400-405
[2]   Dopamine β-hydroxylase deficiency impairs cellular immunity [J].
Alaniz, RC ;
Thomas, SA ;
Perez-Melgosa, M ;
Mueller, K ;
Farr, AG ;
Palmiter, RD ;
Wilson, CB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) :2274-2278
[3]  
Bean AGD, 1999, J IMMUNOL, V162, P3504
[4]   Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent [J].
Bekker, LG ;
Moreira, AL ;
Bergtold, A ;
Freeman, S ;
Ryffel, B ;
Kaplan, G .
INFECTION AND IMMUNITY, 2000, 68 (12) :6954-6961
[5]   DISSEMINATED TUBERCULOSIS IN INTERFERON-GAMMA GENE-DISRUPTED MICE [J].
COOPER, AM ;
DALTON, DK ;
STEWART, TA ;
GRIFFIN, JP ;
RUSSELL, DG ;
ORME, IM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2243-2247
[6]   Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis [J].
Cooper, AM ;
Magram, J ;
Ferrante, J ;
Orme, IM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) :39-45
[7]  
DEVI S, 1995, J IMMUNOL, V154, P5376
[8]   AN ESSENTIAL ROLE FOR INTERFERON-GAMMA IN RESISTANCE TO MYCOBACTERIUM-TUBERCULOSIS INFECTION [J].
FLYNN, JL ;
CHAN, J ;
TRIEBOLD, KJ ;
DALTON, DK ;
STEWART, TA ;
BLOOM, BR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2249-2254
[9]   TUMOR-NECROSIS-FACTOR-ALPHA IS REQUIRED IN THE PROTECTIVE IMMUNE-RESPONSE AGAINST MYCOBACTERIUM-TUBERCULOSIS IN MICE [J].
FLYNN, JL ;
GOLDSTEIN, MM ;
CHAN, J ;
TRIEBOLD, KJ ;
PFEFFER, K ;
LOWENSTEIN, CJ ;
SCHREIBER, R ;
MAK, TW ;
BLOOM, BR .
IMMUNITY, 1995, 2 (06) :561-572
[10]  
Huffnagle GB, 1996, J IMMUNOL, V157, P4529